Skip to search formSkip to main contentSkip to account menu

SCH 51344

Known as: SCH-51344, SCH51344 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AminoquinolinesPyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 2376: AXL receptor tyrosine kinase stimulates cell softening and cancer progression via Rac signaling pathway
Cancer cells exhibit different biophysical properties, such as cell stiffness and elasticity, compared with normal cells. It is… 
Review
1999
Review
1999
SCH 51344, An Inhibitor of RAS/RAC‐Mediated Cell Morphology Pathway
Abstract: RAS interacts with multiple targets in the cell and controls at least two signaling pathways, one regulating… 
1997
1997
SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway
RAS interacts with multiple targets in the cell and controls at least two signaling pathways, one regulating extracellular signal… 
Review
1997
Review
1997
[Inhibition of RAS-transformation by SCH51344].
RAS controls at least two signaling pathways, one regulating extracellular signal-regulated kinase (ERK) activation and the other… 
1997
1997
[Inhibition of RAS-transformation by SCH51344].
  • Ku Cc
  • 1997
  • Corpus ID: 57840894
RAS controls at least two signaling pathways, one regulating extracellular signal-regulated kinase (ERK) activation and the other… 
1995
1995
SCH 51344 inhibits ras transformation by a novel mechanism.
A pyrazolo-quinoline compound, 6-methoxy-4-[2-[(2-hydroxyethoxyl)-ethyl]amino]-3-methyl-1M-pyrazo lo [3,4-b]quinoline (SCH 51344… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)